Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,693 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Postoperative prognosis of pancreatic cancer with para-aortic lymph node metastasis: a multicenter study on 822 patients.
Sho M, Murakami Y, Motoi F, Satoi S, Matsumoto I, Kawai M, Honda G, Uemura K, Yanagimoto H, Kurata M, Fukumoto T, Akahori T, Kinoshita S, Nagai M, Nishiwada S, Unno M, Yamaue H, Nakajima Y. Sho M, et al. Among authors: nakajima y. J Gastroenterol. 2015 Jun;50(6):694-702. doi: 10.1007/s00535-014-1005-4. Epub 2014 Oct 24. J Gastroenterol. 2015. PMID: 25341657
Reappraisal of peritoneal washing cytology in 984 patients with pancreatic ductal adenocarcinoma who underwent margin-negative resection.
Satoi S, Murakami Y, Motoi F, Uemura K, Kawai M, Kurata M, Sho M, Matsumoto I, Yanagimoto H, Yamamoto T, Mizuma M, Unno M, Hashimoto Y, Hirono S, Yamaue H, Honda G, Nagai M, Nakajima Y, Shinzeki M, Fukumoto T, Kwon AH. Satoi S, et al. Among authors: nakajima y. J Gastrointest Surg. 2015 Jan;19(1):6-14; discussion 14. doi: 10.1007/s11605-014-2637-7. Epub 2014 Oct 15. J Gastrointest Surg. 2015. PMID: 25316482
Potential role of surgical resection for pancreatic cancer in the very elderly.
Kinoshita S, Sho M, Yanagimoto H, Satoi S, Akahori T, Nagai M, Nishiwada S, Yamamoto T, Hirooka S, Yamaki S, Ikeda N, Kwon AH, Nakajima Y. Kinoshita S, et al. Among authors: nakajima y. Pancreatology. 2015 May-Jun;15(3):240-6. doi: 10.1016/j.pan.2015.03.015. Epub 2015 Apr 8. Pancreatology. 2015. PMID: 25888010
Importance of resectability status in neoadjuvant treatment for pancreatic cancer.
Sho M, Akahori T, Tanaka T, Kinoshita S, Nagai M, Tamamoto T, Ohbayashi C, Hasegawa M, Kichikawa K, Nakajima Y. Sho M, et al. Among authors: nakajima y. J Hepatobiliary Pancreat Sci. 2015 Jul;22(7):563-70. doi: 10.1002/jhbp.258. Epub 2015 Apr 29. J Hepatobiliary Pancreat Sci. 2015. PMID: 25921623
Optimal indication of neoadjuvant chemoradiotherapy for pancreatic cancer.
Sho M, Akahori T, Tanaka T, Kinoshita S, Nagai M, Nishiwada S, Tamamoto T, Nishiofuku H, Ohbayashi C, Hasegawa M, Kichikawa K, Nakajima Y. Sho M, et al. Among authors: nakajima y. Langenbecks Arch Surg. 2015 May;400(4):477-85. doi: 10.1007/s00423-015-1304-0. Epub 2015 May 1. Langenbecks Arch Surg. 2015. PMID: 25929828
Phase I study assessing the feasibility of the triple combination chemotherapy of SOXIRI (S-1/oxaliplatin/irinotecan) in patients with unresectable pancreatic ductal adenocarcinoma.
Yanagimoto H, Satoi S, Sho M, Akahori T, Yamamoto T, Hirooka S, Yamaki S, Kotsuka M, Ryota H, Kinoshita S, Nishiwada S, Nagai M, Ikeda N, Tsuta K, Nakajima Y, Kon M. Yanagimoto H, et al. Among authors: nakajima y. Cancer Chemother Pharmacol. 2016 Jan;77(1):35-41. doi: 10.1007/s00280-015-2928-z. Epub 2015 Dec 8. Cancer Chemother Pharmacol. 2016. PMID: 26645403 Clinical Trial.
3,693 results